ULTRALIFE CORP — Director's Dealing 2023

Mar 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2023-03-07

Reporting Person: Saeli Thomas Louis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-07	Common Stock; $.10 par value	P	5000	$4.0466	Acquired	75446	Direct

Footnotes

F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 to $4.05. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported in this Form 4.